ES2645204T3 - Dispositivos de estimulación - Google Patents
Dispositivos de estimulación Download PDFInfo
- Publication number
- ES2645204T3 ES2645204T3 ES12768458.7T ES12768458T ES2645204T3 ES 2645204 T3 ES2645204 T3 ES 2645204T3 ES 12768458 T ES12768458 T ES 12768458T ES 2645204 T3 ES2645204 T3 ES 2645204T3
- Authority
- ES
- Spain
- Prior art keywords
- microstimulator
- stimulation
- controller
- variations
- signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 381
- 238000003780 insertion Methods 0.000 claims abstract description 91
- 230000037431 insertion Effects 0.000 claims abstract description 91
- 230000003750 conditioning effect Effects 0.000 claims description 34
- 230000004048 modification Effects 0.000 claims description 26
- 238000012986 modification Methods 0.000 claims description 26
- 238000000576 coating method Methods 0.000 claims description 24
- 239000011248 coating agent Substances 0.000 claims description 13
- 230000001143 conditioned effect Effects 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 210000004907 gland Anatomy 0.000 description 105
- 210000001508 eye Anatomy 0.000 description 62
- 210000001519 tissue Anatomy 0.000 description 62
- 239000012790 adhesive layer Substances 0.000 description 47
- 239000003990 capacitor Substances 0.000 description 46
- 210000003205 muscle Anatomy 0.000 description 46
- 210000005036 nerve Anatomy 0.000 description 45
- 210000004279 orbit Anatomy 0.000 description 44
- 230000005291 magnetic effect Effects 0.000 description 37
- 210000004561 lacrimal apparatus Anatomy 0.000 description 36
- 238000000034 method Methods 0.000 description 34
- 238000002224 dissection Methods 0.000 description 30
- 210000000744 eyelid Anatomy 0.000 description 29
- 239000010410 layer Substances 0.000 description 23
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 22
- 206010013774 Dry eye Diseases 0.000 description 22
- 230000005540 biological transmission Effects 0.000 description 22
- 238000002560 therapeutic procedure Methods 0.000 description 19
- 239000000835 fiber Substances 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 239000011521 glass Substances 0.000 description 17
- 238000011084 recovery Methods 0.000 description 16
- 230000005669 field effect Effects 0.000 description 15
- 210000000988 bone and bone Anatomy 0.000 description 14
- 238000002513 implantation Methods 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 208000006735 Periostitis Diseases 0.000 description 13
- 239000011247 coating layer Substances 0.000 description 13
- 210000003460 periosteum Anatomy 0.000 description 13
- 210000003484 anatomy Anatomy 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 230000004936 stimulating effect Effects 0.000 description 12
- 239000000853 adhesive Substances 0.000 description 11
- 230000001070 adhesive effect Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 230000003287 optical effect Effects 0.000 description 10
- 210000000795 conjunctiva Anatomy 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 230000004489 tear production Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 230000004913 activation Effects 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 210000003625 skull Anatomy 0.000 description 7
- 239000012530 fluid Substances 0.000 description 6
- 210000003128 head Anatomy 0.000 description 6
- 239000007943 implant Substances 0.000 description 6
- 238000002595 magnetic resonance imaging Methods 0.000 description 6
- 210000004083 nasolacrimal duct Anatomy 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 230000024883 vasodilation Effects 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000001061 forehead Anatomy 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000004175 meibomian gland Anatomy 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000002454 frontal bone Anatomy 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 229910000457 iridium oxide Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000002474 sphenoid bone Anatomy 0.000 description 3
- 210000003670 sublingual gland Anatomy 0.000 description 3
- 239000003356 suture material Substances 0.000 description 3
- 210000003582 temporal bone Anatomy 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 2
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000004424 eye movement Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000003302 ferromagnetic material Substances 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 208000002780 macular degeneration Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 210000002241 neurite Anatomy 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000006461 physiological response Effects 0.000 description 2
- 229960001416 pilocarpine Drugs 0.000 description 2
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 210000001913 submandibular gland Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- 210000001170 unmyelinated nerve fiber Anatomy 0.000 description 2
- 229910000859 α-Fe Inorganic materials 0.000 description 2
- 241000288673 Chiroptera Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 201000002287 Keratoconus Diseases 0.000 description 1
- 208000035719 Maculopathy Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010052143 Ocular discomfort Diseases 0.000 description 1
- 206010030043 Ocular hypertension Diseases 0.000 description 1
- 206010072139 Ocular rosacea Diseases 0.000 description 1
- 208000003435 Optic Neuritis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000002367 Retinal Perforations Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000027073 Stargardt disease Diseases 0.000 description 1
- 208000004350 Strabismus Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000004079 adrenergic fiber Anatomy 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000007175 bidirectional communication Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 230000006854 communication Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012073 inactive phase Substances 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 208000029233 macular holes Diseases 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 210000001595 mastoid Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017311 musculoskeletal movement, spinal reflex action Effects 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- 206010029864 nystagmus Diseases 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 239000000734 parasympathomimetic agent Substances 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 201000004768 pinguecula Diseases 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- -1 tear plugs Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37205—Microstimulators, e.g. implantable through a cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36046—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
- A61N1/37223—Circuits for electromagnetic coupling
- A61N1/37229—Shape or location of the implanted or external antenna
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Electromagnetism (AREA)
- Acoustics & Sound (AREA)
- Electrotherapy Devices (AREA)
- Prostheses (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161473141P | 2011-04-07 | 2011-04-07 | |
| US201161473141P | 2011-04-07 | ||
| US201161523732P | 2011-08-15 | 2011-08-15 | |
| US201161523732P | 2011-08-15 | ||
| US13/298,042 US8918181B2 (en) | 2010-11-16 | 2011-11-16 | Systems and methods for treatment of dry eye |
| US201113298042 | 2011-11-16 | ||
| PCT/US2012/032629 WO2012139063A2 (en) | 2011-04-07 | 2012-04-06 | Stimulation devices and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2645204T3 true ES2645204T3 (es) | 2017-12-04 |
Family
ID=46969854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12768458.7T Active ES2645204T3 (es) | 2011-04-07 | 2012-04-06 | Dispositivos de estimulación |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP3263175B1 (cg-RX-API-DMAC7.html) |
| JP (5) | JP6169559B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN103747834B (cg-RX-API-DMAC7.html) |
| AU (3) | AU2012239966B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013025671A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2832463A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2645204T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2013149420A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012139063A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9821159B2 (en) | 2010-11-16 | 2017-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
| CA2817589A1 (en) | 2010-11-16 | 2012-05-24 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
| US9265956B2 (en) | 2013-03-08 | 2016-02-23 | Oculeve, Inc. | Devices and methods for treating dry eye in animals |
| EP2967817B1 (en) | 2013-03-12 | 2021-03-10 | Oculeve, Inc. | Implant delivery devices and systems |
| JP6655004B2 (ja) * | 2013-03-14 | 2020-02-26 | マイクロン デバイシーズ， エルエルシー | 無線植込み型電力受信機システム及び方法 |
| US10155108B2 (en) | 2013-04-19 | 2018-12-18 | Oculeve, Inc. | Nasal stimulation devices and methods |
| RU2547960C1 (ru) * | 2014-01-09 | 2015-04-10 | Владимир Александрович Шипилов | Способ лечения глазной поверхности при синдроме "сухого глаза" |
| AU2015223184B2 (en) * | 2014-02-25 | 2020-07-02 | Oculeve, Inc. | Polymer formulations for nasolacrimal stimulation |
| US9687652B2 (en) | 2014-07-25 | 2017-06-27 | Oculeve, Inc. | Stimulation patterns for treating dry eye |
| GB201414695D0 (en) * | 2014-08-19 | 2014-10-01 | Femeda Ltd | Electrostimulation related devices and methods |
| EP3209371A4 (en) * | 2014-10-22 | 2018-10-24 | Oculeve, Inc. | Implantable nasal stimulator systems and methods |
| EP3209372B1 (en) * | 2014-10-22 | 2020-07-15 | Oculeve, Inc. | Stimulation devices for treating dry eye |
| CA2965514A1 (en) | 2014-10-22 | 2016-04-28 | Oculeve, Inc. | Contact lens for increasing tear production |
| AU2016277825B2 (en) | 2015-06-16 | 2019-04-18 | The Regents Of The University Of Colorado, A Body Corporate | Nasolacrimal implants and related methods for tear stimulation |
| US11291847B2 (en) | 2015-06-16 | 2022-04-05 | The Regents Of The University Of Colorado, A Body Corporate | Systems and methods for preventing, diagnosing, and/or treating one or more medical conditions via neuromodulation |
| CA3002841C (en) * | 2015-10-21 | 2024-03-19 | NeuSpera Medical Inc. | Devices, systems, and methods for stimulation therapy |
| ITUB20154761A1 (it) | 2015-10-29 | 2017-04-29 | Resono Ophthalmic S R L | Sistema di elettrodo e relativo dispositivo per il trattamento di patologie dell?occhio, in particolare dell?occhio secco |
| US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
| AU2017206728B2 (en) | 2016-01-12 | 2019-11-21 | Boston Scientific Neuromodulation Corporation | Implantable device programming management |
| US10252048B2 (en) | 2016-02-19 | 2019-04-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
| US11007367B2 (en) * | 2016-03-16 | 2021-05-18 | Nova Oculus Canada Manufacturing Ulc | Microcurrent device for the treatment of visual disease |
| EP3452166A4 (en) | 2016-05-02 | 2019-12-18 | Oculeve, Inc. | INTRANASAL STIMULATION FOR THE TREATMENT OF DISEASES OF MEIBOM'S GLANDS AND BLEPHARITIS |
| EP3522981A4 (en) * | 2016-10-04 | 2020-06-03 | The Charles Stark Draper Laboratory, Inc. | IMPLANTABLE WIRELESS MICROSTIMULATOR FOR PERIPHERAL NERVES |
| US12233017B2 (en) | 2016-10-14 | 2025-02-25 | Olympic Ophthalmics, Inc. | Quiet handheld devices and methods for treatment of disorders |
| EP3525735B1 (en) * | 2016-10-14 | 2025-07-16 | Olympic Ophthalmics, Inc. | Device for stimulating tear production |
| CN110022755A (zh) | 2016-12-02 | 2019-07-16 | 奥库利维公司 | 用于干眼症预测和治疗建议的设备和方法 |
| CN106861041B (zh) * | 2017-02-21 | 2018-08-31 | 王乐今 | 植入式眼外肌神经肌肉刺激器及其参数设置方法 |
| CN108686301B (zh) * | 2017-04-07 | 2022-02-15 | 林伯刚 | 用于刺激视神经纤维的装置 |
| WO2018232338A1 (en) | 2017-06-16 | 2018-12-20 | AesculaTech, Inc. | Thermoresponsive polymers and uses thereof |
| JP7349154B2 (ja) | 2017-08-18 | 2023-09-22 | イノコン メディカル エーピーエス | 神経の電気刺激のためのシステム |
| WO2019034223A1 (en) * | 2017-08-18 | 2019-02-21 | Innocon Medical Aps | SYSTEM FOR ELECTRICAL STIMULATION OF NERFS |
| TWI667860B (zh) | 2018-02-09 | 2019-08-01 | 鉅旺生技股份有限公司 | 植入式醫材遠距離無線充電強化結構 |
| WO2020060882A1 (en) * | 2018-09-18 | 2020-03-26 | Verily Life Sciences Llc | Stimulation system with monolithic-lead component connected to skull mount package |
| CN113015552B (zh) | 2018-11-16 | 2025-07-22 | 威里利生命科学有限责任公司 | 用于高密度神经接口的分支近端连接器 |
| US11298537B2 (en) * | 2019-03-26 | 2022-04-12 | Twenty Twenty Therapeutics Llc | Non-invasive periocular device for dry-eye treatment and closed-loop methods for operating same |
| US11376432B2 (en) | 2019-03-26 | 2022-07-05 | Twenty Twenty Therapeutics Llc | Non-invasive periocular device for dry-eye treatment |
| US12023498B2 (en) * | 2019-07-12 | 2024-07-02 | Biovisics Medical, Inc. | Ocular therapy modes and systems |
| WO2021113486A1 (en) * | 2019-12-03 | 2021-06-10 | Biovisics Medical, Inc. | Systems, implantable devices and methods for vision related stimulation |
| CN111714793A (zh) * | 2020-05-21 | 2020-09-29 | 温州医科大学附属眼视光医院 | 一种高精度睑板腺诊疗仪 |
| US12310886B2 (en) * | 2020-08-03 | 2025-05-27 | Verily Life Sciences Llc | Ophthalmic devices, systems and methods for treating dry eye |
| KR102451859B1 (ko) * | 2020-10-12 | 2022-10-11 | 고려대학교 산학협력단 | 3차원 망막 자극 디바이스 |
| CN112386795B (zh) * | 2020-11-18 | 2024-12-31 | 北京大学人民医院 | 一种植入式神经电刺激系统 |
| CN113058155B (zh) * | 2021-03-19 | 2024-09-03 | 中国科学院空天信息创新研究院 | 电引导治疗装置及方法 |
| WO2023076105A1 (en) * | 2021-10-25 | 2023-05-04 | Twenty Twenty Therapeutics Llc | Fluid osmolarity sensing and associated systems, devices, and methods |
| US20250281747A1 (en) * | 2024-03-11 | 2025-09-11 | Verily Life Sciences Llc | System, method, and apparatus for underlid home-based meibomian gland disease treatment via resistive heating and magnetic-based mechanical stimulation |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU577549B2 (en) * | 1983-09-14 | 1988-09-29 | Jacob Zabara | Neurocybernetic prothesis |
| WO1994000188A1 (en) * | 1992-06-24 | 1994-01-06 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
| CA2336190A1 (en) * | 1998-07-06 | 2000-01-13 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of urinary incontinence |
| EP2275167A3 (en) * | 1999-03-24 | 2014-04-30 | Second Sight Medical Products, Inc. | Visual prosthesis |
| JP4781576B2 (ja) * | 2001-02-28 | 2011-09-28 | 株式会社ニデック | 眼内埋め込み型視覚刺激装置 |
| US6907293B2 (en) * | 2001-03-30 | 2005-06-14 | Case Western Reserve University | Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US6735480B2 (en) * | 2001-06-29 | 2004-05-11 | Abbott Laboratories | Electro-acupuncture device with D-shaped stimulation electrodes |
| US6792312B2 (en) * | 2001-09-06 | 2004-09-14 | Medtronic, Inc. | Connector module having internal weld plates |
| JP4295627B2 (ja) * | 2002-03-27 | 2009-07-15 | シーブイアールエックス， インコーポレイテッド | 電極構造体および循環系反射の制御におけるその使用方法 |
| US7142909B2 (en) * | 2002-04-11 | 2006-11-28 | Second Sight Medical Products, Inc. | Biocompatible bonding method and electronics package suitable for implantation |
| US20050165458A1 (en) * | 2002-05-09 | 2005-07-28 | Boveja Birinder R. | Method and system to provide therapy for depression using electroconvulsive therapy(ECT) and pulsed electrical stimulation to vagus nerve(s) |
| US7587246B2 (en) * | 2002-06-03 | 2009-09-08 | Med-El Elektronedizinische Geraete Gmbh | Implantable device with flexible interconnect to coil |
| JP4242195B2 (ja) * | 2003-04-10 | 2009-03-18 | 俊夫 大城 | 光治療器具 |
| US7571007B2 (en) * | 2004-04-12 | 2009-08-04 | Advanced Neuromodulation Systems, Inc. | Systems and methods for use in pulse generation |
| US7359751B1 (en) * | 2004-05-05 | 2008-04-15 | Advanced Neuromodulation Systems, Inc. | Clinician programmer for use with trial stimulator |
| EP1812104B1 (en) * | 2004-10-20 | 2012-11-21 | Boston Scientific Limited | Leadless cardiac stimulation systems |
| US7555345B2 (en) * | 2005-03-11 | 2009-06-30 | Medtronic, Inc. | Implantable neurostimulator device |
| US7920915B2 (en) * | 2005-11-16 | 2011-04-05 | Boston Scientific Neuromodulation Corporation | Implantable stimulator |
| US8606362B2 (en) * | 2005-07-08 | 2013-12-10 | Boston Scientific Neuromodulation Corporation | Current output architecture for an implantable stimulator device |
| JP2007044323A (ja) * | 2005-08-11 | 2007-02-22 | Nidek Co Ltd | 視覚再生補助装置 |
| US8005526B2 (en) * | 2005-08-31 | 2011-08-23 | The Regents Of The University Of Michigan | Biologically integrated electrode devices |
| US7729758B2 (en) * | 2005-11-30 | 2010-06-01 | Boston Scientific Neuromodulation Corporation | Magnetically coupled microstimulators |
| US7444181B2 (en) * | 2005-12-14 | 2008-10-28 | Boston Scientific Neuromodulation Corporation | Techniques for sensing and adjusting a compliance voltage in an implantable stimulator device |
| US20070250135A1 (en) * | 2006-04-21 | 2007-10-25 | Bartz-Schmidt Karl U | Compound subretinal prostheses with extra-ocular parts and surgical technique therefore |
| US20070255333A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Neuromodulation therapy for perineal or dorsal branch of pudendal nerve |
| EP2068710A4 (en) * | 2006-09-27 | 2009-10-21 | Huntington Medical Res Inst | APPARATUS AND METHOD FOR TREATING AN OBSTRUCTIVE SLEEP APNEA |
| DE102006048819A1 (de) * | 2006-10-10 | 2008-04-17 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Vorrichtung mit einem Grundkörper |
| CA2666420C (en) * | 2006-10-18 | 2014-01-28 | Boston Scientific Neuromodulation Corporation | Multi-electrode implantable stimulator device with a single current path decoupling capacitor |
| EP2114514B1 (en) * | 2007-02-16 | 2016-10-12 | Second Sight Medical Products, Inc. | Flexible circuit electrode array with film support |
| EP2185236B1 (en) * | 2007-07-27 | 2015-10-07 | Second Sight Medical Products | Implantable device for the brain |
| WO2009018518A1 (en) * | 2007-08-02 | 2009-02-05 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Methods and systems for achieving a physiological response by pudendal nerve stimulation and bockade |
| WO2009048580A1 (en) * | 2007-10-09 | 2009-04-16 | Imthera Medical, Inc. | Apparatus, system, and method for selective stimulation |
| US8457757B2 (en) | 2007-11-26 | 2013-06-04 | Micro Transponder, Inc. | Implantable transponder systems and methods |
| US8165694B2 (en) * | 2008-01-29 | 2012-04-24 | Boston Scientific Neuromodulation Corporation | Thermal management of implantable medical devices |
| DE102008002228A1 (de) * | 2008-06-05 | 2009-12-10 | Biotronik Crm Patent Ag | Langgestrecktes Implantat mit externer Energieeinkopplung |
| AU2009308359B2 (en) * | 2008-10-22 | 2014-11-13 | Advanced Neuromodulation Systems, Inc. | Method for processing electrodes for stimulation lead |
| WO2010069317A1 (en) * | 2008-12-19 | 2010-06-24 | Neurodan A/S | Bursts of electrical pulses in the treatment of pelvic disorders by electrical nerve stimulation |
| US8494641B2 (en) * | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
| US9233254B2 (en) * | 2009-02-17 | 2016-01-12 | Boston Scientific Neuromodulation Corporation | Selectable boost converter and charge pump for compliance voltage generation in an implantable stimulator device |
| WO2010123704A2 (en) * | 2009-04-24 | 2010-10-28 | Medtronic, Inc. | Incontinence therapy |
| JP5578540B2 (ja) * | 2009-07-31 | 2014-08-27 | 株式会社ニデック | 視覚再生補助装置及び視覚再生補助装置の製造方法 |
| AU2009222439B2 (en) * | 2009-09-28 | 2011-07-21 | Cochlear Limited | Method and circuitry for measurement and control of stimulation current |
| CA2817589A1 (en) * | 2010-11-16 | 2012-05-24 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
-
2012
- 2012-04-06 JP JP2014504050A patent/JP6169559B2/ja not_active Expired - Fee Related
- 2012-04-06 AU AU2012239966A patent/AU2012239966B2/en not_active Ceased
- 2012-04-06 ES ES12768458.7T patent/ES2645204T3/es active Active
- 2012-04-06 WO PCT/US2012/032629 patent/WO2012139063A2/en not_active Ceased
- 2012-04-06 EP EP17167504.4A patent/EP3263175B1/en not_active Not-in-force
- 2012-04-06 EP EP12768458.7A patent/EP2694156B8/en not_active Not-in-force
- 2012-04-06 CA CA2832463A patent/CA2832463A1/en not_active Abandoned
- 2012-04-06 BR BR112013025671A patent/BR112013025671A2/pt not_active IP Right Cessation
- 2012-04-06 CN CN201280028006.9A patent/CN103747834B/zh not_active Expired - Fee Related
- 2012-04-06 CN CN201610069087.7A patent/CN105727444B/zh not_active Expired - Fee Related
- 2012-04-06 RU RU2013149420/14A patent/RU2013149420A/ru not_active Application Discontinuation
-
2016
- 2016-02-26 AU AU2016201224A patent/AU2016201224B2/en not_active Ceased
-
2017
- 2017-06-28 JP JP2017125971A patent/JP6362734B2/ja not_active Expired - Fee Related
-
2018
- 2018-05-08 AU AU2018203202A patent/AU2018203202B2/en not_active Ceased
- 2018-06-26 JP JP2018120583A patent/JP6596124B2/ja not_active Expired - Fee Related
-
2019
- 2019-09-27 JP JP2019176723A patent/JP6746767B2/ja not_active Expired - Fee Related
-
2020
- 2020-08-05 JP JP2020132985A patent/JP2020192343A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2694156A2 (en) | 2014-02-12 |
| EP2694156A4 (en) | 2014-10-01 |
| AU2012239966B2 (en) | 2015-11-26 |
| AU2018203202A1 (en) | 2018-05-31 |
| JP2020192343A (ja) | 2020-12-03 |
| JP2014514070A (ja) | 2014-06-19 |
| EP3263175B1 (en) | 2021-11-24 |
| EP2694156B1 (en) | 2017-06-14 |
| AU2018203202B2 (en) | 2020-10-08 |
| RU2013149420A (ru) | 2015-05-20 |
| AU2016201224B2 (en) | 2018-02-08 |
| BR112013025671A2 (pt) | 2017-12-12 |
| JP6746767B2 (ja) | 2020-08-26 |
| JP6362734B2 (ja) | 2018-07-25 |
| WO2012139063A3 (en) | 2012-12-27 |
| CA2832463A1 (en) | 2012-10-11 |
| JP2019213969A (ja) | 2019-12-19 |
| CN105727444A (zh) | 2016-07-06 |
| CN103747834A (zh) | 2014-04-23 |
| JP6169559B2 (ja) | 2017-07-26 |
| AU2012239966A1 (en) | 2013-05-02 |
| JP2017164576A (ja) | 2017-09-21 |
| JP6596124B2 (ja) | 2019-10-23 |
| CN105727444B (zh) | 2018-10-09 |
| WO2012139063A2 (en) | 2012-10-11 |
| JP2018196732A (ja) | 2018-12-13 |
| EP3263175A1 (en) | 2018-01-03 |
| EP2694156B8 (en) | 2017-08-09 |
| CN103747834B (zh) | 2016-03-02 |
| AU2016201224A1 (en) | 2016-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2645204T3 (es) | Dispositivos de estimulación | |
| US10835748B2 (en) | Stimulation devices and methods | |
| US11771908B2 (en) | Systems and methods for treatment of dry eye | |
| AU2017204067B2 (en) | Systems and methods for treatment of dry eye |